Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1990 Aug;212(2):125–131. doi: 10.1097/00000658-199008000-00002

Axillary dissection in melanoma. Prognostic variables in node-positive patients.

R G Bevilacqua 1, D G Coit 1, A Rogatko 1, R N Younes 1, M F Brennan 1
PMCID: PMC1358045  PMID: 2375645

Abstract

We evaluated the importance of 14 clinical and pathologic variables as determinants of prognosis in patients with malignant melanoma and positive regional lymph nodes at axillary dissection. The records of 197 patients operated on between 1974 and 1984 were reviewed. Univariate analysis indicated as prognostically significant the number (p less than 0.001) and percentage (p less than 0.001) of positive nodes, highest nodal status (p less than 0.001), macroscopic or microscopic nodal metastases (p = 0.002), presence or absence of extranodal disease (p = 0.003), clinical stage (III versus less than III, p = 0.015), and site (considered as trunk versus other locations, p = 0.02). However, by multivariate analysis, only three variables were shown to be independent determinants of survival: percentage of positive nodes (p = 0.004), presence or absence of extranodal disease (p = 0.012), and site (trunk versus other locations, p = 0.019). Combining these three variables, subsets of patients with markedly different prognoses could be generated. It is possible to predict a favorable outcome for patients with less than 10% positive nodes, no extranodal disease, and a primary lesion at a site other than the trunk. It is also possible to recognize that the prognosis is very poor for patients with extranodal disease and truncal primary lesions, regardless of the percentage of positive lymph nodes. Finally it was verified that the prognosis is always unfavorable when the percentage of positive lymph nodes is very high.

Full text

PDF
125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERG J. W. The significance of axillary node levels in the study of breast carcinoma. Cancer. 1955 Jul-Aug;8(4):776–778. doi: 10.1002/1097-0142(1955)8:4<776::aid-cncr2820080421>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  2. Callery C., Cochran A. J., Roe D. J., Rees W., Nathanson S. D., Benedetti J. K., Elashoff R. M., Morton D. L. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes. Ann Surg. 1982 Jul;196(1):69–75. doi: 10.1097/00000658-198207000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cohen M. H., Ketcham A. S., Felix E. L., Li S. H., Tomaszewski M. M., Costa J., Rabson A. S., Simon R. M., Rosenberg S. A. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg. 1977 Nov;186(5):635–642. doi: 10.1097/00000658-197711000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coit D. G., Brennan M. F. Extent of lymph node dissection in melanoma of the trunk or lower extremity. Arch Surg. 1989 Feb;124(2):162–166. doi: 10.1001/archsurg.1989.01410020032004. [DOI] [PubMed] [Google Scholar]
  5. Day C. L., Jr, Sober A. J., Lew R. A., Mihm M. C., Jr, Fitzpatrick T. B., Kopf A. W., Harris M. N., Gumport S. L., Raker J. W., Malt R. A. Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes. Cancer. 1981 Mar 1;47(5):955–962. doi: 10.1002/1097-0142(19810301)47:5<955::aid-cncr2820470523>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  6. FORTNER J. G., BOOHER R. J., PACK G. T. RESULTS OF GROIN DISSECTION FOR MALIGNANT MELANOMA IN 220 PATIENTS. Surgery. 1964 Apr;55:485–494. [PubMed] [Google Scholar]
  7. Finck S. J., Giuliano A. E., Mann B. D., Morton D. L. Results of ilioinguinal dissection for stage II melanoma. Ann Surg. 1982 Aug;196(2):180–186. doi: 10.1097/00000658-198208000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fortner J. G., Woodruff J., Schottenfeld D., Maclean B. Biostatistical basis of elective node dissection for malignant melanoma. Ann Surg. 1977 Jul;186(1):101–103. doi: 10.1097/00000658-197707000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kissin M. W., Simpson D. A., Easton D., White H., Westbury G. Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma. Br J Surg. 1987 Nov;74(11):1023–1026. doi: 10.1002/bjs.1800741122. [DOI] [PubMed] [Google Scholar]
  10. Koh H. K., Sober A. J., Day C. L., Jr, Lew R. A., Kopf A. W., Lamar W., Ben Cosimi A., Wood W. C., Mihm M. C., Jr, Malt R. A. Prognosis of clinical stage I melanoma patients with positive elective regional node dissection. J Clin Oncol. 1986 Aug;4(8):1238–1244. doi: 10.1200/JCO.1986.4.8.1238. [DOI] [PubMed] [Google Scholar]
  11. Link C. L. Confidence intervals for the survival function using Cox's proportional-hazard model with covariates. Biometrics. 1984 Sep;40(3):601–609. [PubMed] [Google Scholar]
  12. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  13. McCarthy J. G., Haagensen C. D., Herter F. P. The role of groin dissection in the management of melanoma of the lower extremity. Ann Surg. 1974 Feb;179(2):156–159. doi: 10.1097/00000658-197402000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McCarthy W. H., Shaw H. M., Thompson J. F., Milton G. W. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet. 1988 Jun;166(6):497–502. [PubMed] [Google Scholar]
  15. Rayner C. R. The results of node resection for clinically enlarged lymph nodes in malignant melanoma. Br J Plast Surg. 1981 Apr;34(2):152–156. doi: 10.1016/s0007-1226(81)80084-7. [DOI] [PubMed] [Google Scholar]
  16. Roses D. F., Provet J. A., Harris M. N., Gumport S. L., Dubin N. Prognosis of patients with pathologic stage II cutaneous malignant melanoma. Ann Surg. 1985 Jan;201(1):103–107. [PMC free article] [PubMed] [Google Scholar]
  17. Singletary S. E., Shallenberger R., Guinee V. F., McBride C. M. Melanoma with metastasis to regional axillary or inguinal lymph nodes: prognostic factors and results of surgical treatment in 714 patients. South Med J. 1988 Jan;81(1):5–9. doi: 10.1097/00007611-198801000-00002. [DOI] [PubMed] [Google Scholar]
  18. Smith J. A., 3rd, Gamez-Araujo J. J., Gallager H. S., White E. C., McBride C. M. Carcinoma of the breast: analysis of total lymph node involvement versus level of metastasis. Cancer. 1977 Feb;39(2):527–532. doi: 10.1002/1097-0142(197702)39:2<527::aid-cncr2820390221>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES